THE USE OF TESTOSTERONE PROPIONATE IN FUNCTIONAL BLEEDING

Abstract

The effect of testosterone propionate was studied in 25 cases of abnormal uterine bleeding. In 21 of these, no palpable evidence of organic pelvic disease was found. In 4, examination revealed small intramural myomata. With doses varying from 300 to 1000 mgm. per month, the excessive bleeding was controlled in all but 2 cases. Treatment in this dosage inhibits menstruation and arrests the endometrium at the early proliferative phase, preventing the development of progestational changes.